Franklin Resources Inc. Has $321.61 Million Stake in Humana Inc. $HUM

Franklin Resources Inc. lifted its stake in Humana Inc. (NYSE:HUM) by 914.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,255,665 shares of the insurance provider’s stock after acquiring an additional 1,131,893 shares during the period. Franklin Resources Inc. owned 1.04% of Humana worth $321,613,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund boosted its holdings in Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after acquiring an additional 4,351 shares during the period. Long Focus Capital Management LLC bought a new position in shares of Humana in the third quarter worth about $34,212,000. AMG National Trust Bank lifted its position in shares of Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after purchasing an additional 8,744 shares during the last quarter. Aberdeen Group plc boosted its stake in Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after purchasing an additional 43,442 shares during the period. Finally, Alberta Investment Management Corp acquired a new stake in Humana in the 3rd quarter valued at approximately $4,735,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE HUM opened at $355.48 on Tuesday. The firm has a market capitalization of $42.68 billion, a price-to-earnings ratio of 38.02, a PEG ratio of 2.00 and a beta of 0.76. Humana Inc. has a one year low of $163.11 and a one year high of $356.01. The business has a fifty day simple moving average of $252.05 and a 200 day simple moving average of $233.24. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana Inc. will post 9 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. Humana’s payout ratio is presently 37.86%.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of research analyst reports. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. UBS Group boosted their target price on shares of Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Barclays increased their price target on shares of Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Finally, Truist Financial raised their price target on shares of Humana from $270.00 to $320.00 and gave the stock a “hold” rating in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fourteen have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $286.13.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.